On May 10, 2023, Mr. George H. Lowell submitted to the board of directors of BiondVax Pharmaceuticals Ltd. his resignation from his position as a member of the Board, effective May 12, 2023. Mr. Lowell, who had served as a Board member since 2008, did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Mr. Lowell will remain on the Company's Scientific Advisory board and will begin serving as a liaison between the Advisory Board and the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 USD | -2.82% | -8.00% | -42.06% |
1st Jan change | Capi. | |
---|---|---|
-42.06% | 1.54M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- BVXV Stock
- News Scinai Immunotherapeutics Ltd.
- BiondVax Pharmaceuticals Ltd. Announces Resignation of George H. Lowell as Member of the Board